Not applicableUnknownNCT05883670What this trial is testingReal-world Study of Serplulimab in 2L and Above Treatment of Cervical CancerWho this might be right forCervical Cancer Shandong University 118
Testing effectiveness (Phase 2)Looking for participantsNCT05081609What this trial is testingInvestigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesWho this might be right forAdvanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more Ascendis Pharma Oncology Division A/S 345
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405151What this trial is testingA Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)Who this might be right forOesophageal Squamous Cell Carcinoma Merck Sharp & Dohme LLC 60
Testing effectiveness (Phase 2)Looking for participantsNCT06445972What this trial is testingSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)Who this might be right forGastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more Merck Sharp & Dohme LLC 210